Booz Allen Hamilton pulled back 3.6% on the week to $75.76, reversing a slice of the sharp mid-August run — and the question now is whether the sector re-rating that drove the stock has paused or peaked.
The week's price action looks like a consolidation rather than a breakdown. The one-month gain is still +16%, and peers held up better: LDOS added 1.8% on the week and SAIC was essentially flat at +0.4%. That BAH underperformed its own peer group this week is worth noting, but the gap is not dramatic. More interesting is what has happened inside the short book. Short interest spiked sharply on August 14 — reaching around 10.6 million shares, the highest reading in the 30-day history — before collapsing back to 8.7 million shares (7.2% of free float) by Tuesday. That intraday look suggests some opportunistic shorting into the rally high, quickly covered, rather than a structural rebuild of the bear position.
The lending market tells a nuanced story this week. Availability remains extremely loose — roughly 3,600% — meaning the pool of shares available to borrow dwarfs what is actually lent out. There is no squeeze pressure. But cost to borrow has quietly risen about 30% on the week to 0.44%, its highest level in a month, even as it remains objectively cheap in absolute terms. That uptick in borrow cost, combined with the brief spike in short shares on August 14, points to a small cluster of new shorts testing the rally — and retreating quickly when the thesis didn't immediately pay off. Options positioning is mildly more cautious than usual. The put/call ratio is running at 0.91, slightly above its 20-day average of 0.87, but the z-score of 0.60 means this is nowhere near a stressed reading. Positioning overall looks watchful rather than worried.
The Street remains divided in ways that haven't resolved since spring. Most of the analyst action in recent weeks has been mixed: UBS lifted its target to $78 while staying Neutral, roughly in line with where the stock traded — not a ringing endorsement. Goldman Sachs holds a Sell with a $65 target, well below the current price. B of A maintains Underperform with a $75 target, essentially at-market. Against those bearish anchors, Cantor Fitzgerald stays Overweight despite cutting its target from $160 to $140 — a range that looks disconnected from where the stock actually trades at $75.76, and which should be treated with caution as a data point. The consensus mean target of $85.58 implies about 13% upside from here. EV/EBITDA is running near 9.8x, with a trailing PE of 11.7x — both have expanded meaningfully over the past month as the stock recovered. Factor scores are unremarkable: EPS momentum ranks in the 34th percentile, short score sits at the 27th percentile, and the dividend score is maxed at 100 though the dividend data in the snapshot is stale. The bear case centres on continued civil spending disruption; the bull case rests on a sequential revenue recovery through FY2027 and what is still a discounted multiple relative to BAH's own history.
Insider activity has been consistently one-directional. The CEO sold 60,138 shares at $77.00 in May; the COO sold alongside him. The most recent trade — the Chief Accounting Officer selling 469 shares at $77.92 in mid-August — is small in dollar terms ($36,500) but adds to a picture where no insider has been a buyer in the visible window. Net 90-day insider flow is negative in the hundreds of thousands of dollars. The sells in May occurred right around the current trading level, which is a reference point worth holding.
The most recent earnings print on July 24 produced a one-day gain of 8.8% and a five-day follow-through of 5.8% — the catalyst that lit the sector rally and drove BAH's sharp August move. The next event is scheduled for October 30. Between now and then, the stock trades without a near-term earnings floor, which makes how the analyst community responds to any government spending headlines the primary price driver to monitor.
See the live data behind this article on ORTEX.
Open BAH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
